HONY Capital
弘毅投资
elsewhere's corpus does not cover HONY Capital as a subject. The only mentions in the bundle are two 2022 references showing it as a co-investor alongside Source Code Capital and春华创投 in Sirius Pharma's Series A round — these name-drop HONY Capital in passing rather than profile it. No entity card, founding date, strategy, team, or scale information is provided.
AI-generated — may contain errors, please verify.
Coverage
From Medallion to AI-Native Asset Management: GIM Closes Three Funding Rounds
Will a Century-Old Asset Management Industry Be Rewritten by AI?
5Y News | AI-Native Investment Management Firm GIM Closes Tens of Millions of Dollars in Series A Funding
Model capabilities, agent capabilities, and closed-loop research capabilities.
5Y News｜Aikelian Biotechnology Completes $68.7 Million Funding Round
Aikelian Biotech has successfully completed an oversubscribed $68.7 million funding round.
The Day Munger Died: 18 WeChat Moments About Him
Mourning the Passing of a Wise Mind
Buyouts in China: A "Boy Who Cried Wolf" Fable
After so many cycles of euphoria and heartbreak, will Chinese buyouts finally deliver a different ending this time?
Code Moment | "Starna Therapeutics" Announces 150 Million Yuan Series A Funding Round, Source Code Capital Participates
Focus on extrahepatic delivery to build a core platform with global competitiveness.
The World Is Out There, and We Have to Go | 8 Young FreeS Fund Entrepreneurs Named to Forbes China "30 Under 30" List
Meet youth. Meet innovation and the extraordinary.
